Timeline

Voting rights breakdown

Notice details

Beneficial owner

ADDEX THERAPEUTICS LTD

Crossing down of 25% thresholds on share and purchase positions and crossing up of 33 1/3%, 50% and 66 2/3% thresholds on sale position following the Securities purchase agreement signed on April 3, 2023. At the same date, conditions of 24,230,772 warrants have been changed. The exercise price of 31,578,948 warrants was erroneously reported in the original publication published on April 12, 2023. The exercise price of USD 0.1583 per share initially reported has been corrected to USD 0.1667 per share.